Literature DB >> 3933003

Activated and unactivated forms of human erythrocyte aldose reductase.

S K Srivastava, G A Hair, B Das.   

Abstract

Aldose reductase (alditol:NADP+ 1-oxidoreductase, EC 1.1.1.21) has been partially purified from human erythrocytes by DEAE-cellulose (DE-52) column chromatography. This enzyme is activated severalfold upon incubation with 10 microM each glucose 6-phosphate, NADPH, and glucose. The activation of the enzyme was confirmed by following the oxidation of NADPH as well as the formation of sorbitol with glucose as substrate. The activated form of aldose reductase exhibited monophasic kinetics with both glyceraldehyde and glucose (Km of glucose = 0.68 mM and Km of glyceraldehyde = 0.096 mM), whereas the native (unactivated) enzyme exhibited biphasic kinetics (Km of glucose = 9.0 and 0.9 mM and Km of glyceraldehyde = 1.1 and 0.14 mM). The unactivated enzyme was strongly inhibited by aldose reductase inhibitors such as sorbinil, alrestatin, and quercetrin, and by phosphorylated intermediates such as ADP, glycerate 3-phosphate, glycerate 1,3-bisphosphate, and glycerate 2,3-trisphosphate. The activated form of the enzyme was less susceptible to inhibition by aldose reductase inhibitors and phosphorylated intermediates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933003      PMCID: PMC390821          DOI: 10.1073/pnas.82.21.7222

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  AN AUTOMATED FLUOROMETRIC METHOD FOR DETERMINATION OF LACTIC DEHYDROGENASE IN SERUM.

Authors:  L BROOKS; H G OLKEN
Journal:  Clin Chem       Date:  1965-08       Impact factor: 8.327

Review 2.  Mechanisms initiating cataract formation. Proctor Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1974-10

Review 3.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  Purification and immunologic identification of aldose reductases.

Authors:  K H Gabbay; E S Cathcart
Journal:  Diabetes       Date:  1974-05       Impact factor: 9.461

5.  A rapid simplified assay for galactokinase activity in whole blood.

Authors:  E Beutler; F Matsumoto
Journal:  J Lab Clin Med       Date:  1973-11

6.  Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway.

Authors:  S F Travis; A D Morrison; R S Clements; A I Winegrad; F A Oski
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

7.  Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.

Authors:  K H Gabbay; L O Merola; R A Field
Journal:  Science       Date:  1966-01-14       Impact factor: 47.728

8.  Aldose reductase in retinal mural cells.

Authors:  S M Buzney; R N Frank; S D Varma; T Tanishima; K H Gabbay
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-05       Impact factor: 4.799

9.  Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor.

Authors:  E Dvornik; N Simard-Duquesne; M Krami; K Sestanj; K H Gabbay; J H Kinoshita; S D Varma; L O Merola
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

10.  Sorbitol and other polyols in lens, adipose tissue and urine in diabetes mellitus.

Authors:  D J Heaf; D J Galton
Journal:  Clin Chim Acta       Date:  1975-08-18       Impact factor: 3.786

View more
  7 in total

1.  Structural and kinetic modifications of aldose reductase by S-nitrosothiols.

Authors:  S Srivastava; B L Dixit; K V Ramana; A Chandra; D Chandra; A Zacarias; J M Petrash; A Bhatnagar; S K Srivastava
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  The role of Cys-298 in aldose reductase function.

Authors:  Ganesaratnam K Balendiran; Michael R Sawaya; Frederick P Schwarz; Gomathinayagam Ponniah; Richard Cuckovich; Malkhey Verma; Duilio Cascio
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

3.  3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.

Authors:  Farhad R Danesh; Mehran M Sadeghi; Nail Amro; Carrie Philips; Lixia Zeng; Sun Lin; Atul Sahai; Yashpal S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

Review 4.  The effect of oxidants on biomembranes and cellular metabolism.

Authors:  S K Srivastava; N H Ansari; S Liu; A Izban; B Das; G Szabo; A Bhatnagar
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

5.  Human erythrocyte sorbitol metabolism and the role of sorbitol dehydrogenase.

Authors:  Y Nagasaka; S Fujii; T Kaneko
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

Review 6.  Physiological and Pathological Roles of Aldose Reductase.

Authors:  Mahavir Singh; Aniruddh Kapoor; Aruni Bhatnagar
Journal:  Metabolites       Date:  2021-09-27

7.  Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.

Authors:  G Bhanuprakash Reddy; A Satyanarayana; N Balakrishna; Radha Ayyagari; M Padma; K Viswanath; J Mark Petrash
Journal:  Mol Vis       Date:  2008-03-24       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.